The title compound was prepared by treatment of 4-bromo-1-phenyl-1Hpyrazol-3-ol with sodium hydride/methyl iodide in good yield. Detailed spectroscopic data ( 1 H NMR, 13 C NMR, 15 N NMR, IR, MS) are presented.
Bromo(hetero)arenes are valuable starting materials for further functionalization, for instance via metalation reactions (halogen-metal exchange) [1] or transition-metal-catalyzed cross coupling reactions [2] [3] [4] . With an OH-or OR function in ortho-position to the bromo atom, such (hetero)arenes can be considered as potential precursors for condensed systems involving a ring-oxygen atom (condensed furans, pyranes) [5] . However, for some of the above mentioned functionalization reactions, free hydroxy groups are unfavourable, for instance in metalation reactions [6] or in Suzukitype cross couplings [7] . In such cases, the OH group has to be masked. In this regard, a possible option is to transform the OH into the very stable OMe group. The O-Me bond then can be cleaved in the course of the cyclization reaction into the O-containing ring system employing, for instance, pyridine hydrochloride as the reagent [8] .
We here present the synthesis of 4-bromo-3-methoxy-1-phenyl-1H-pyrazole (2), with a protected OH-group in position 3 and a bromo substituent in position 4 of the pyrazole nucleus, which can be considered as a desirable starting compound for further transformation. The preparation of 2 was carried out according to a standard method for O-alkylation, namely by reaction of 4-bromo-1-phenyl-1H-pyrazol-3-ol (1) [9] with methyl iodide in alkaline medium, which afforded the title compound in 88% yield after column chromatograpy (Scheme 1). Although compound 2 is reported in a patent application, neither an experimental procedure for its preparation nor spectroscopic/physical data, was provided [10] . Thus, a detailed characterization of 2 including IR, MS and NMR ( 1 H, 13 C, 15 N) spectral data as well as microanalytical data is given in the Experimental.
Experimental
The melting point was determined on a Mel-Temp (Capillary Melting point Apparatus) and is uncorrected. Mass spectrum was recorded on a Waters ZQ 2000 instrument (APCI+, 20 V) and IR spectrum on a Perkin Elmer Spectrum GX FT-IR System instrument (KBr-disc). The elemental analysis was performed with an Exeter Analytical CE-440 Elemental Analyzer. All NMR spectra were recorded from CDCl 3 solutions on a Bruker Avance 500 instrument with a 'directly' detecting broadband observe probe (BBFO) at 298 K (500.13 MHz for 1 H, 125.76 MHz for 13 C, 50.68 MHz for 15 N). The centre of the solvent signal was used as an internal standard which was related to TMS with δ = 7.26 ppm ( 1 H in CDCl 3 ) and δ = 77.0 ppm ( 13 C in CDCl 3 ). The digital resolutions were 0.2 Hz/data point in the 1 H and 0.4 Hz/data point in the 1 H-coupled 13 C-NMR spectra (gated decoupling). The 15 N NMR spectrum (gradient-selected 15 N, 1 H-HMBC) was referenced against external nitromethane.
4-Bromo-3-methoxy-1-phenyl-1H-pyrazole (2)
A solution of 4-bromo-1-phenyl-1H-pyrazol-3-ol (1) (3.825 g, 16.0 mmol) in dry DMF (20 mL) was cooled to 0 °C under an inert atmosphere and NaH (60% dispersion in mineral oil, 640 mg, 16.0 mmol) was added portionwise. After stirring for 15 min, methyl iodide (1.2 mL, 19.2 mmol) was added dropwise at 0 ºC. The mixture was warmed to r.t. and stirred at 60 ºC for 1 h (TLC control, eluent: ethyl acetate-n-hexane, 1:10). Then, 10 mL of water were added and the mixture was extracted with ethyl acetate. The organic layers were combined, washed with brine and dried over anhydrous Anal. Calcd for C 5 H 9 BrN 2 O: C, 47.46%; H, 3.58%; N, 11.07%. Found: C, 47.08%; H, 3.42%; N 10.72%.
